CARDIOPHARMA ApS — Credit Rating and Financial Key Figures

CARDIOPHARMA ApS (CVR number: 13966273) is a company from GENTOFTE. The company reported a net sales of 2.6 mDKK in 2023, demonstrating a growth of 497.8 % compared to the previous year. The operating profit percentage was at 97.6 % (EBIT: 2.6 mDKK), while net earnings were 2910.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was 11.6 %, which can be considered good and Return on Equity (ROE) was 10.3 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 99.8 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. CARDIOPHARMA ApS's liquidity measured by quick ratio was 118.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.